Mestrum, S. G. C., Roanalis, B. Y. V., de Wit, N. C. J., Drent, R. J. M., Boonen, B. T., van Hemert, W. L. W., Hopman, A. H. N., Ramaekers, F. C. S., & Leers, M. P. G. (2024). MDS and AML show elevated fractions of CD34-positive blast cell populations with a high anti-apoptotic versus proliferation ratio. Leukemia Research, 142, Article 107520. https://doi.org/10.1016/j.leukres.2024.107520
Moshi, J. M., Ummelen, M., Smedts, F., Ramaekers, F. C. S., & Hopman, A. H. N. (2024). Inhibition of cytosine 5-hydroxymethylation during progression of cancer precursor lesions in the uterine cervix. PLOS ONE, 19(4), Article e0297008. https://doi.org/10.1371/journal.pone.0297008
Mestrum, S. G. C., Vanblarcum, R., de Wit, N. C. J., Drent, R. J. M., Boonen, B. T., van Hemert, W. L. W., Hopman, A. H. N., Ramaekers, F. C. S., & Leers, M. P. G. (2023). Impact of the gating strategy for Ki-67 and Bcl-2 on the determination of proliferation and anti-apoptosis data by flow cytometry in non-malignant bone marrow aspirates and aspirates from patients with myeloid malignancies. Data in brief, 49(1), Article 109284. https://doi.org/10.1016/j.dib.2023.109284
Moshi, J. M., Ummelen, M., Broers, J. L. V., Ramaekers, F. C. S., & Hopman, A. H. N. (2023). Impact of antigen retrieval protocols on the immunohistochemical detection of epigenetic DNA modifications. Histochemistry and Cell Biology, 159(6), 513-526. https://doi.org/10.1007/s00418-023-02187-4
Zelissen, R., Ahmadian, S., Montilla-Rojo, J., Timmer, E., Ummelen, M., Hopman, A., Smeets, H., & van Tienen, F. (2023). Fusion of Wild-Type Mesoangioblasts with Myotubes of mtDNA Mutation Carriers Leads to a Proportional Reduction in mtDNA Mutation Load. International Journal of Molecular Sciences, 24(3), Article 2679. https://doi.org/10.3390/ijms24032679
Mestrum, S. G. C., de Wit, N. C. J., Cremers, E. M. P., Drent, R. J. M., Ramaekers, F. C. S., Hopman, A. H. N., & Leers, M. P. G. (2022). The Proliferation Index of Erythroid Cells Predicts the Development of Transfusion-dependence in Myelodysplastic Syndrome Patients With Mildly Reduced Hemoglobin Levels at Initial Diagnosis. HemaSphere, 6(12), Article e804. https://doi.org/10.1097/HS9.0000000000000804
Moshi, J. M., Ummelen, M., Broers, J. L. V., Smedts, F., Van de Vijver, K. K., Cleutjens, J. P. M., Litjens, R. J. N. T. M., Ramaekers, F. C. S., & Hopman, A. H. N. (2022). SOX2 expression in the pathogenesis of premalignant lesions of the uterine cervix: its histo-topographical distribution distinguishes between low- and high-grade CIN. Histochemistry and Cell Biology, 158(6), 545-559. https://doi.org/10.1007/s00418-022-02145-6
Mestrum, S. G. C., Vanblarcum, R. B. Y., Drent, R. J. M., Boonen, B. T., van Hemert, W. L. W., Ramaekers, F. C. S., Hopman, A. H. N., & Leers, M. P. G. (2022). Proliferative and anti-apoptotic fractions in maturing hematopoietic cell lineages and their role in homeostasis of normal bone marrow. Cytometry Part A, 101(7), 552-563. https://doi.org/10.1002/cyto.a.24558
Mestrum, S. G. C., Cremers, E. M. P., de Wit, N. C. J., Drent, R. J. M., Ramaekers, F. C. S., Hopman, A. H. N., & Leers, M. P. G. (2022). Optimized gating strategy and supporting flow cytometry data for the determination of the Ki-67 proliferation index in the diagnosis of myelodysplastic syndrome. Data in brief, 41, Article 107976. https://doi.org/10.1016/j.dib.2022.107976
Mestrum, S. G. C., Cremers, E. M. P., de Wit, N. C. J., Drent, R. J. M., Ramaekers, F. C. S., Hopman, A. H. N., & Leers, M. P. G. (2022). Integration of the Ki-67 proliferation index into the Ogata score improves its diagnostic sensitivity for low-grade myelodysplastic syndromes. Leukemia Research, 113, Article 106789. https://doi.org/10.1016/j.leukres.2022.106789